Author:
Gray Eleanor R,Mordaka Justyna M,Christoforou Efthimia R,von Bargen Kristine,Potts Nicola D,Xyrafaki Christina,Silva Ana-Luisa,Stolarek-Januszkiewicz Magdalena,Anton Katarzyna,Powalowska Paulina K,Andreazza Simonetta,Tomassini Alessandro,Palmer Rebecca N,Cooke Aishling,Osborne Robert J,Balmforth Barnaby W
Abstract
Abstract
Background
RNA is a critical analyte for unambiguous detection of actionable mutations used to guide treatment decisions in oncology. Currently available methods for gene fusion detection include molecular or antibody-based assays, which suffer from either being limited to single-gene targeting, lack of sensitivity, or long turnaround time. The sensitivity and predictive value of next generation sequencing DNA-based assays to detect fusions by sequencing intronic regions is variable, due to the extensive size of introns. The required depth of sequencing and input nucleic acid required can be prohibitive; in addition it is not certain that predicted gene fusions are actually expressed.
Results
Herein we describe a method based on pyrophosphorolysis to include detection of gene fusions from RNA, with identical assay steps and conditions to detect somatic mutations in DNA [1], permitting concurrent assessment of DNA and RNA in a single instrument run.
Conclusion
The limit of detection was under 6 molecules/ 6 µL target volume. The workflow and instrumentation required are akin to PCR assays, and the entire assay from extracted nucleic acid to sample analysis can be completed within a single day.
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献